Category and country
CDMO companies in Germany
7 cdmo profiles in Germany. Every profile is hand-reviewed with leadership, certifications, and public sources.
Where does cdmo cluster in Germany?
Heidelberg (2), Berlin (1), Dessau-Rosslau (1), and Frankfurt (1) Most visible profiles: BioSpring GmbH, AGC Biologics Heidelberg, ProBioGen, and FyoniBio.
Which standards are already visible?
GMP (6), GLP (1), and FDA-Inspected (2) Latest review: 24 April 2026. Review cycle: April 2026.
Full list
CDMO profiles in Germany
7 profiles match the active filter.
Current review cycle
BioSpring GmbH
FrankfurtGermanyCDMO
Frankfurt-based oligonucleotide CDMO producing antisense oligonucleotides, siRNA, guide RNA and mRNA at research-to-commercial scale, with a documented cGMP track record since 2007 and FDA-inspected commercial supply since 2020.
- Lead
- Sylvia WojczewskiCo-Founder and Chief Executive Officer
- Scale
- Research through multi-kilogram commercial oligonucleotide API
Current review cycle
AGC Biologics Heidelberg
HeidelbergGermanyCDMO
Heidelberg biomanufacturing site within AGC Biologics, providing microbial, pDNA, and mRNA process development and GMP manufacturing services from Germany.
- Lead
- Patrik JonssonChief Executive Officer
- Scale
- Commercial and clinical manufacturing platform
Current review cycle
ProBioGen
BerlinGermanyCDMO
Berlin CDMO and biologics technology company providing cell-line development, process development, and GMP manufacturing services for complex biopharmaceuticals.
- Lead
- Volker SandigChief Executive Officer and Chief Scientific Officer
- Scale
- Commercial and clinical biopharma platform
Current review cycle
FyoniBio
HeidelbergGermanyCDMO
Berlin biologics-development and bioanalytical platform supporting cell-line development, CMC, and analytical packages for biopharma programmes.
- Lead
- Philippe UlsemerCo-Founder and Chief Executive Officer
- Scale
- Integrated biologics-development platform
Current review cycle
Rentschler Biopharma
LaupheimGermanyCDMO
Laupheim biologics CDMO anchor focused on mammalian production, late-stage development, and regulated commercial manufacturing.
- Lead
- Prof. Dr. Uwe BüchelerInterim Chief Executive Officer
- Scale
- Clinical-to-commercial CDMO manufacturing
Current review cycle
Vetter Pharma
RavensburgGermanyCDMO
Ravensburg aseptic-fill and injectable CDMO anchor operating one of Europe's most important sterile manufacturing networks.
- Lead
- Henryk Badack, Titus Ottinger, and Carsten PressManaging Directors
- Scale
- Global injectable CDMO manufacturing
Current review cycle
IDT Biologika
Dessau-RosslauGermanyCDMO
German CDMO platform for viral vaccines, cell and gene therapy, and aseptic fill-finish manufacturing in Dessau-Rosslau. The verified March 2026 record ties the facility to current official executive leadership and live biologics production infrastructure.
- Lead
- Dr. Sally ChoeCo-CEO
- Scale
- Commercial biologics CDMO
Related brief
Read deeper on this category
European CDMO Capacity 2026: Biologics, Fill-Finish, Small Molecule
Where to look for biologics, fill-finish, small-molecule, and specialised CDMO capacity across Europe in 2026 — 33 CDMOs in the directory across 9 countries, organised by what they actually do and where they sit.
Open briefFAQ
Frequently asked questions on this category
- What is a CDMO?
- A Contract Development and Manufacturing Organization handles drug development and production for other pharma or biotech companies. The work spans process development, scale-up, GMP manufacturing, fill-finish, packaging, and analytical testing.
- Which European countries have the most CDMO capacity?
- Switzerland and Germany lead by depth and quality (Basel, Heidelberg, Mainz). Poland adds large-scale manufacturing capacity, Lithuania has a growing biologics CDMO presence anchored in Vilnius, and the Nordics carry strong fill-finish and aseptic operators in Denmark and Sweden.
- How are these CDMO companies verified?
- Every profile is hand-reviewed against an audit framework: leadership identity confirmed by primary source, physical site address sourced from official disclosures, regulatory matrix (GMP / ISO-13485 / GLP / FDA-Inspected) backed by certification documents, and a registry note explaining the company's current operating context.
- Can I compare two CDMO providers side by side?
- Yes — use the Compare button on any company card to add it to a comparison set (up to 3 companies), then open the /compare page for a side-by-side view of leadership, certifications, and operating scale.
Next step
Compare companies or open the wider market.
Use the compare tool to view two or three companies side by side, or open the country hub for the full market view.